Loading...

Everest Medicines Limited

1952.HK•HKSE
Healthcare
Biotechnology
HK$62.10
HK$-1.80(-2.82%)

Everest Medicines Limited (1952.HK) Company Profile & Overview

Explore Everest Medicines Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Everest Medicines Limited (1952.HK) Company Profile & Overview

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.

SectorHealthcare
IndustryBiotechnology
CEOYongqing Luo

Contact Information

https://www.everestmedicines.com
Plaza 66, Shanghai, 200040

Company Facts

665 Employees
IPO DateOct 9, 2020
CountryCN
Actively Trading

Frequently Asked Questions

;